Načítá se...
Body fluid biomarkers in multiple sclerosis: how far we have come and how they could affect the clinic now and in the future
Multiple Sclerosis (MS) is an autoimmune inflammatory disease of the central nervous system (CNS) which affects over 2.5 million people worldwide. Although MS has been extensively studied, many challenges still remain in regards to treatment, diagnosis, and prognosis. Typically, prognosis and indivi...
Uloženo v:
| Vydáno v: | Expert Rev Clin Immunol |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4326231/ https://ncbi.nlm.nih.gov/pubmed/25523168 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/1744666X.2015.991315 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|